What is OCCI?
OCCI, Inc. operates as a network of research centers focused on conducting phase II-IV clinical trials across Psychiatry, Neurology, and General Medicine. Despite its local ownership, OCCI has garnered national recognition from pharmaceutical and biotechnology firms, positioning itself as a leading clinical trials site. The organization actively engages potential participants through direct outreach and online assessments, inviting them to explore opportunities within its research studies.
How much funding has OCCI raised?
OCCI has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in OCCI
PPP
Public-Private Partnership
What's next for OCCI?
The substantial capital raised, particularly the recent strategic investment, signals OCCI's readiness for significant expansion and advancement in its clinical research capabilities. This late-stage funding context suggests a focus on scaling operations, potentially enhancing infrastructure, expanding research portfolios, or forging new strategic partnerships within the life sciences industry. OCCI is poised to leverage this financial momentum to further solidify its standing and impact in clinical trial execution.
See full OCCI company page